Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.prismmedico.in | |
Market Cap | 15.76 Cr. | |
Enterprise Value(EV) | Cr. | - |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -0.20 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-09 |
Industry PE | 15.59 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 24.77 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 1.05 | Calculated using Price: 26.00 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.61 Cr. | 6,063,428 Shares |
FaceValue | 10 | |
About Prism Medico and Pharmacy Ltd. | ||
The main object of the company was to carry on the trading in goods and commodities.. During the year ended March 31, 2008 the company earned Interest Income from loans and advances given and is presently engaged in the investing in shares and other securities and other financing activities. |
1 Day |
|
+1.34% |
1 Week |
|
-6.62% |
1 Month |
|
-11.51% |
3 Month |
|
-0.62% |
6 Month |
|
-9.38% |
1 Year |
|
+86.02% |
2 Year |
|
+273.40% |
5 Year |
|
-34.88% |
10 Year |
|
+49.80% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -0.55 | -0.51 | -3.15 | -0.15 | 2.85 | -0.38 | -1.00 | -2.90 | -0.55 | |
Return on Capital Employed (%) | -0.55 | -0.49 | -3.11 | 0.37 | 2.26 | -0.52 | -1.35 | -3.91 | -0.74 | |
Return on Assets (%) | -0.54 | -0.47 | -3.05 | -0.15 | 2.47 | -0.26 | -0.60 | -2.18 | -0.55 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 2 | 2 | 13 | 13 | 13 | 13 | 13 | 13 | 15 | 15 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Curr. Liab. | 0 | 0 | 0 | 0 | 4 | 9 | 9 | 0 | 0 | 0 | |
Minority Int. | |||||||||||
Equity & Liab. | 2 | 2 | 13 | 13 | 17 | 22 | 21 | 12 | 15 | 15 | |
Non Curr. Assets | 0 | 10 | 11 | 10 | 2 | 2 | 0 | 0 | 5 | ||
Curr. Assets | 2 | 2 | 3 | 2 | 7 | 20 | 19 | 12 | 15 | 11 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 2 | 2 | 13 | 13 | 17 | 22 | 21 | 12 | 15 | 15 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 0 | 0 | 21 | 36 | 27 | 17 | 8 | 1 | 1 | ||
Other Income | 0 | 0 | 0 | 0 | 0 | ||||||
Total Income | 0 | 0 | 0 | 21 | 37 | 27 | 17 | 8 | 1 | 1 | |
Total Expenditure | 0 | 0 | 0 | -21 | -36 | -27 | -17 | -9 | -1 | -1 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Interest | |||||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 1 | 0 | 0 | -1 | 0 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | -1 | -1 | -4 | 0 | -2 | 3 | ||
Cash Fr. Inv. | 0 | 0 | 0 | 1 | 4 | 0 | 2 | -3 | |||
Cash Fr. Finan. | 0 | 0 | 1 | 0 | |||||||
Net Change | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | |||
Cash & Cash Eqvt | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Thu, 09 Nov 2023
Revision In Outcome Of Board Meeting Held On 08Th November 2023. Dear Sir/Madam With reference to the captioned subject please find the attached revised outcome of Board Meeting. You are requested to kindly take the same on record and oblige.Thanking You. |
Wed, 08 Nov 2023
Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. Dear Sir/Madam Pursuant to Regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors of the company at their meeting held today (i.e. 08th November 2023) which commenced at 04:00 P.M. and concluded at 05:30 P.M. have inter alia approved the following: ? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter and half year ended 30th September 2023 alongwith the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige.Thanking You. |
Wed, 08 Nov 2023
Details Of Related Party Transactions (RPT'S) As Per Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. Dear Sir/Madam Pursuant to Regulation 23(9) of SEBI (LODR) Regulations 2015 please find enclosed herewith details of related party transactions for the half year ended 30th September 2023.You are requested to kindly take the same on record and oblige.Thanking You. |
Tue, 05 Dec 2023 |
|
|
|
|
|